2020-12-13 |
|
|
and Counterclaims with Respect to U.S. Patent Nos. 9,669,008 and 9,808,442 filed by Silvergate Pharmaceuticals… 2018
17 May 2021
1:18-cv-01962
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-07-22 |
136 |
Notice of Service |
Byrn on Infringement of U.S. Patent Nos. 9,669,008; 9,808,442; 10,039,745; and 10,154,987; and (2) Opening…John D. Mahan, Jr., M.D. on Infringement of U.S. Patent 9,808,442 and 10,154,987 filed by Silvergate Pharmaceuticals… 2018
17 May 2021
1:18-cv-01962
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-10-19 |
145 |
Notice of Service |
Stephen Byrn on the Infringement of U.S. Patents 10,039,745 and 10,154,987 filed by Silvergate Pharmaceuticals… 2018
17 May 2021
1:18-cv-01962
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-10-30 |
147 |
Attachment 2 |
2 through 24 as obvious “over Van Wagenen (US 6,211,244 B1) as evidenced by
Kajiyama et al. (US 6,656,492…two new patents. Amneal and Bionpharma were coordinated as to
the first four Epaned patents for good… first set of Epaned
patents to issue (the ’008, ’442, ’745, and ’987 patents). (C.A. No. 19-678 against…involves two patents that did not issue until September 2020 (the ’868 and ’482
patents), but that are…asserts the same six patents against both Amneal and Bionpharma. All six
patents deal with the same technology |
External link to document |
2020-12-09 |
166 |
Stipulation of Dismissal |
and Counterclaims with Respect to U.S. Patent Nos. 9,669,008 and 9,808,442 by Silvergate Pharmaceuticals… 2018
17 May 2021
1:18-cv-01962
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |